Professional Documents
Culture Documents
Erwinanto Department of Cardiology and Vascular Medicine Division of Cardiovascular, Department of Internal Medicine Padjadjaran University School of Medicine/Hasan Sadikin Hospital Bandung
The cardiovascular continuum of events Ischemia = oxygen supply and demand imbalance
Myocardial Ischemia
CAD
plaque
Atherosclerosis
Risk Factors ( DYSLIPIDEMIA , BP, DM, Insulin Resistance, Platelets, Fibrinogen, etc)
80
60
68
% MI
40
18
14
20
0
50%
50%-70%
70%
% Stenosis
Falk E et al. Circulation 1995;92:657-671
CAD
Atherosclerosis
Risk Factors ( DYSLIPIDEMIA , BP, DM, Insulin Resistance, Platelets, Fibrinogen, etc)
CAD
Atherosclerosis
Risk Factors ( DYSLIPIDEMIA , BP, DM, Insulin Resistance, Platelets, Fibrinogen, etc)
Myocardial Ischemia
Remodeling
CAD
Atherosclerosis
Risk Factors ( DYSLIPIDEMIA , BP, DM, Insulin Resistance, Platelets, Fibrinogen, etc)
Chronic plaque change: Stable angina Acute plaque change : Unstable angina Acute MI
Unstable angina
Acute MI = Acute coronary syndrome
DELAY TO THERAPY
2. Out-hospital transport
3. In-hospital evaluation
TYPICAL ANGINA
EQUIVALENT ANGINA
2. LOCATION
3. INDIGESTION 4. UNEXPLAINED WEAKNESS 5. DIAPORESIS 6. SHORTNESS OF BREATH
3. RADIATION
4. UNLIKELINESS
study
Portable chest x-ray ( 30 minutes)
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-91
ST-segment elevation
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
ST-segment depression
T-wave inversion
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
Nondiagnostic changes in ST-segment ot T waves is characterized by: ST-segment deviation of 0.5 mm or T-wave inversion of 0.2 mv.
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
12 hours
- Reperfusion strategy: PCI (90 min) or fibrinolysis (30 min) - ACE-I/ARB - Statin 2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
12 hours
- Reperfusion strategy: PCI (90 min) or fibrinolysis (30 min) - ACE-I/ARB within 24 hours of onset - Statin 2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
Adjunctive treatment
Heparin (UFH/LMWH)
Glycoprotein IIb/IIIa receptor inhibitors Nitroglycerin IV -Adrenoreceptor blockers IV Clopidogrel
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
Chest discomfort suggestive of ischemia Immediate ED assessment and immediate ED general treatment Review initial 12 lead ECG ST elevation or new or presumably new LBBB strongly suspicious for injury Start adjunctive treatment Time from onset of symptoms 12 hours - Reperfusion strategy: PCI (90 min) or fibrinolysis (30 min) - ACE-I/ARB within 24 h of symptom onset) - Statin - High risk: early invasive strategy - Continue ASA, heparin, ACE-I, statin ST-depression or dynamic T-wave inversion strongly suspicious for injury Normal or nondiagnostic changes in ST-segment or Twaves
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90
Chest discomfort suggestive of ischemia Immediate ED assessment and immediate ED general treatment Review initial 12 lead ECG ST elevation or new or presumably new LBBB strongly suspicious for injury Start adjunctive treatment Time from onset of symptoms 12 hours - Reperfusion strategy: PCI (90 min) or fibrinolysis (30 min) - ACE-I/ARB within 24 h of symptom onset) - Statin - High risk: early invasive strategy - Continue ASA, heparin, ACE-I, statin ST-depression or dynamic T-wave inversion strongly suspicious for injury Normal or nondiagnostic changes in ST-segment or Twaves Develops high or intermediate risk criteria or troponin-positive Monitored bed in ED Develops high or intermediate risk criteria or troponin-positive
Start adjunctive treatment 12 hrs Admit to monitored bed Assess risk status
HIGH-RISK PATIENT
1. Refractory chest pain 2. Recurrent/persistent ST deviation 3. Ventricular tachycardia 4. Hemodynamic instability 5. Sign of pump failure 6. Shock within 48 hours
2005 AHA-ILCOR Guidelines for CPR and ECC. Circulation 2005;112 (Suppl):IV-90